Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 78.87M
March 31, 2026 79.24M
December 31, 2025 79.71M
September 30, 2025 80.00M
June 30, 2025 80.15M
March 31, 2025 80.74M
December 31, 2024 81.60M
September 30, 2024 82.04M
June 30, 2024 82.48M
March 31, 2024 82.87M
December 31, 2023 83.03M
September 30, 2023 83.07M
June 30, 2023 83.06M
March 31, 2023 83.06M
December 31, 2022 82.89M
September 30, 2022 83.00M
June 30, 2022 83.43M
March 31, 2022 84.16M
December 31, 2021 84.56M
September 30, 2021 84.97M
June 30, 2021 85.19M
March 31, 2021 85.45M
December 31, 2020 85.54M
September 30, 2020 85.45M
June 30, 2020 85.20M
Date Value
March 31, 2020 85.07M
December 31, 2019 85.61M
September 30, 2019 86.03M
June 30, 2019 86.25M
March 31, 2019 86.22M
December 31, 2018 86.26M
September 30, 2018 86.71M
June 30, 2018 86.80M
March 31, 2018 87.21M
December 31, 2017 87.33M
September 30, 2017 87.53M
June 30, 2017 87.68M
March 31, 2017 88.16M
December 31, 2016 88.20M
September 30, 2016 89.94M
June 30, 2016 89.56M
March 31, 2016 89.55M
December 31, 2015 90.24M
September 30, 2015 91.44M
June 30, 2015 92.88M
March 31, 2015 93.83M
December 31, 2014 94.98M
September 30, 2014 96.78M
June 30, 2014 101.02M
March 31, 2014 102.82M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Neogen Corp. 217.70M
QuidelOrtho Corp. 68.30M
Aspira Women's Health, Inc. 46.63M
VolitionRX Ltd. 12.04M
Lucid Diagnostics, Inc. 190.76M